Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (12) , 3005-3010
- https://doi.org/10.1097/01.ccm.0000242755.74063.ed
Abstract
Capillary leakage, a frequent complication in septic shock, is characterized by loss of intravasal fluid resulting in generalized edema and hemodynamic instability despite massive fluid therapy. We have shown that administration of an established colloid 200/0.5 hydroxyethyl starch (HES) stabilized plasma volume in a porcine septic shock model. Recently, a new HES with a low molecular weight (130 kD) and lower molar substitution (0.42) has been developed. In this study, we compared effects of HES 130/0.42 and HES 200/0.5 on capillary leakage in porcine septic shock. Prospective randomized, controlled animal study. University department of anesthesiology. Fourteen pigs (22.9 +/- 2.8 kg). Anesthetized and mechanically ventilated pigs were observed over 6 hrs. Septic shock was induced with fecal peritonitis (0.75 g.kg of body weight autologous feces). Animals were allocated to volume-replacement therapy with either HES 130/0.42 (n = 5) or HES 200/0.5 (n = 5) and compared with nonseptic controls receiving HES 130/0.42 (n = 4). Infusion rate was titrated to maintain a central venous pressure of 12 mm Hg. Albumin escape rate was calculated using iodine 125-labeled albumin. Plasma volume was determined using chromium-51-tagged erythrocytes. Albumin escape rate increased significantly in both groups in comparison to controls (HES 200/0.5, 45% +/- 3; HES 130/0.42, 38% +/- 5), but this increase was significantly smaller with HES 130/0.42. Both HES 200/0.5 (-14%, not significant) and HES 130/0.42 (-1%, not significant) stabilized plasma volume compared with controls. Systemic oxygenation was not significantly altered in either group. In this porcine septic shock model, HES 130/0.42 attenuated capillary leakage significantly more effectively than HES 200/0.5.Keywords
This publication has 37 references indexed in Scilit:
- Fluid therapy in sepsis with capillary leakageEuropean Journal of Anaesthesiology, 2003
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakageIntensive Care Medicine, 2002
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5Anesthesia & Analgesia, 2001
- A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- Endogenous Endothelin Modulates Blood Pressure, Plasma Volume, and Albumin Escape After Systemic Nitric Oxide BlockadeHypertension, 1997
- The Contribution of Individual Variables to Hotelling's T 2 , Wilks' Λ, and R 2Published by JSTOR ,1993
- Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitisCritical Care Medicine, 1991